Lakshmidurga Drugs & Intermediates Private Limited, a active private limited company, was established on 15 May 2009 in Hyderabad, Telangana, India. Engaging in api manufacturers within the manufacturing sector, it holds CIN: U24233TG2009PTC063687. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹3.00 Cr and a paid-up capital of ₹3.00 Cr.
It upholds a compliant status. Employing 24 professional, Its leadership includes Sai Babu Dodda (Whole-Time Director), Vijayakrishna Ravi (Managing Director). Past directors included Sai Babu Dodda, Vijayakrishna Ravi, Gaddipati Srinivasa Rao. It holds ₹20.55 Cr open charges and ₹10.43 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Plot No.26, Venkata Sai Enclave, 101, Noble Residency, Nizampet, K.P.H.B,, Hyderabad, Telangana, 500072.
U24233TG2009PTC063687
063687
15 May 2009
₹3.00 Cr
₹3.00 Cr
Roc Hyderabad
Unlisted
Active
Explore comprehensive insights into Lakshmidurga Drugs & Intermediates Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sai Babu Dodda | Whole-Time Director | 15 May 2009 | Current |
| Vijayakrishna Ravi | Managing Director | 15 May 2009 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 01 Nov 2009 | Past |
| Pramod Abcsdd | Director | 01 Nov 2009 | Past |
| Pramod Abcsdd | Whole-Time Director | 16 Feb 2012 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Lakshmidurga Drugs & Intermediates Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 72.79% increase. The company also saw a substantial improvement in profitability, with a 44.12% increase in profit. The company's net worth Soared by an impressive increase of 23.92%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Lakshmidurga Drugs & Intermediates had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹205,546,158.00
₹104,300,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 29 Nov 2024 | Hdfc Bank Limited | ₹3.16 M | Open |
| 28 Jul 2017 | Hdfc Bank Limited | ₹20.24 Cr | Open |
| 04 Dec 2010 | State Bank Of India | ₹4.80 Cr | Satisfied |
| 19 Nov 2010 | State Bank Of Hyderabad | ₹5.63 Cr | Satisfied |
Explore comprehensive loan charge details -
Lakshmidurga Drugs & Intermediates has a workforce of 24 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Lakshmidurga Drugs & Intermediates, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Lakshmidurga Drugs & Intermediates's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on A charge with Hdfc Bank Limited amounted to Rs. 0.32 Cr with Charge ID 101011384 was registered on 29 Nov 2024. was documented.
Progress on A charge with Hdfc Bank Limited of Rs. 20.24 Cr registered on 28 Jul 2017 with Charge ID 100128891 was modified on 19 Nov 2024. was documented.
Progress on Lakshmidurga Drugs & Intermediates Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
The activity Lakshmidurga Drugs & Intermediates Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Hyderabad. was completed.
The activity A charge registered on 04 Dec 2010 via Charge ID 10257140 with State Bank Of India was fully satisfied on 08 Sep 2017. was completed.
Progress on A charge registered on 19 Nov 2010 via Charge ID 10256062 with State Bank Of Hyderabad was fully satisfied on 08 Sep 2017. was documented.
The CIN of Lakshmidurga Drugs & Intermediates Private Limited is U24233TG2009PTC063687.
Lakshmidurga Drugs & Intermediates Private Limited is headquartered at Plot No.26, Venkata Sai Enclave, 101, Noble Residency, Nizampet, K.P.H.B,, Hyderabad, Telangana, 500072.
Lakshmidurga Drugs & Intermediates Private Limited was incorporated on 15 May 2009.
The current directors of Lakshmidurga Drugs & Intermediates Private Limited are
The primary industry of Lakshmidurga Drugs & Intermediates Private Limited is Manufacturing.
Lakshmidurga Drugs & Intermediates Private Limited is unlisted.
The authorized capital of Lakshmidurga Drugs & Intermediates Private Limited is ₹3.00 Cr, and the paid-up capital is ₹3.00 Cr.
The compliance status of Lakshmidurga Drugs & Intermediates Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX